Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Surgery Partners (SGRY) Leases (2016 - 2025)

Surgery Partners' Leases history spans 12 years, with the latest figure at $289.2 million for Q4 2025.

  • For Q4 2025, Leases fell 55.89% year-over-year to $289.2 million; the TTM value through Dec 2025 reached $289.2 million, down 55.89%, while the annual FY2025 figure was $289.2 million, 55.89% down from the prior year.
  • Leases for Q4 2025 was $289.2 million at Surgery Partners, down from $747.5 million in the prior quarter.
  • Across five years, Leases topped out at $751.9 million in Q2 2025 and bottomed at $244.5 million in Q3 2023.
  • The 5-year median for Leases is $392.2 million (2021), against an average of $454.9 million.
  • The largest YoY upside for Leases was 181.72% in 2025 against a maximum downside of 55.89% in 2025.
  • A 5-year view of Leases shows it stood at $324.1 million in 2021, then surged by 94.79% to $631.3 million in 2022, then increased by 13.46% to $716.3 million in 2023, then decreased by 8.47% to $655.6 million in 2024, then crashed by 55.89% to $289.2 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Leases are $289.2 million (Q4 2025), $747.5 million (Q3 2025), and $751.9 million (Q2 2025).